Isomorphic Labs closed a $2.1 billion Series B funding round.
The raise positions the company as a leader in AI for drug discovery.
Article poses five key questions following the announcement.
Isomorphic Labs closed a $2.1 billion Series B funding round.
The raise positions the company as a leader in AI for drug discovery.
Article poses five key questions following the announcement.